Contract manufacturer Ajinomoto Bio-Pharma Services is bringing its AstraZeneca production team-up to the U.S.  Already pitching in on AZ's small mo...

AbbVie has pegged multibillion-dollar hopes on Rinvoq to fill the revenue gap when immunology superstar Humira loses U.S. market exclusivity. But that plan, dependen...

Supernus Pharmaceuticals has two key selling points for its newly minted Qelbree: It's the first non-stimulant ADHD drug to win approval in a decade, and it appears ...

A European Medicines Agency official drew a link Tuesday between AstraZeneca's COVID-19 vaccine and the rare reports of blood clots in vaccine recipients. But t...

Study after study has shown the heavy burden on caregivers during the pandemic—especially unpaid ones. They’re more likely than average to report symptoms of anxiety...

Last summer, pharmacy benefits giant Express Scripts tossed Novartis’ psoriasis drug Cosentyx out of its 2021 formulary in favor of Eli Lilly’s lower-cost Taltz. Now...

Until a few years ago, eosinophilic disorders were largely invisible. Only medical specialists and diagnosed patients knew they existed. Thanks in part to marketin...

The U.S. manufacturing partner turning out drug substance for Johnson & Johnson's single-dose COVID-19 vaccine is still waiting on an FDA green light, potentiall...

Pfizer and BioNTech have hustled to produce as many COVID-19 vaccine doses as possible this year, and that effort is paying off in a big way.&nbs...

Bluebird bio and partner Bristol Myers Squibb have outrun Johnson & Johnson and Legend Biotech in snagging the first FDA nod for a BCMA-targeted CAR-T therapy. B...